Publications

Ganner A, Ferrara AM, Sekula P, …, Walz MK, Köttgen A, Eng C, Neumann HPH, Neumann-Haefelin E. Genotype-specific neoplastic risk profiles in patients with VHL disease. Endocr Relat Cancer (2025). Berns H, Weber D, Haas M, Bakey Z, Brislinger-Engelhardt MM, Schmidts M, Walentek P. A homozygous human WNT11 variant is associated with laterality, heart and renal defects. Dis Model Mech (2025). Schlösser RM, Krumbach F, Corrales E, …, Boerries M, Becker K, Knüchel R, Garczyk S, Lüscher B. Multidimensional OMICs reveal ARID1A orchestrated control of DNA damage, splicing, and cell cycle in normal-like and malignant urothelial cells. Mol Oncol (2025). Planells-Cases R, Vorobeva V, Kar S, Schmitt FW, Schulte U, Schrecker M, Hite RK, Fakler B, Jentsch TJ. Endosomal chloride/proton exchangers need inhibitory TMEM9 β-subunits for regulation and prevention of disease-causing overactivity. Nat Commun (2025). Fernandez-Orth J, Koyunlar C, Weiss JM, …, Boerries M, Touw IP, Niemeyer C, Erlacher M, de Pater E. Hematological phenotypes in GATA2 deficiency syndrome arise from aging maladaptation to proliferation and somatic events. Blood Adv (2025). Andreev G, Vollmer T, Zirngibl M, Werner M, Grabbert M, Schilling O, Rogg M, Schell C. Spatial correlation of the extracellular matrix to immune cell phenotypes in the tumor boundary of ccRCC revealed by cyclic immunohistochemistry. Lab Invest (2025). Wiegel J, Helmstädter M, Walz G, Bergen M. Spontaneous Calcium Bursts Organize the Apical Actin Cytoskeleton of Multiciliated Cells. Int J Mol Sci (2025). Wess M, Rogg M, Gueib-Picard C, …, Feilen T, Andreev G, Werner M, Frew I, Grabbert M, Schilling O, Schell C. Versatile roles of annexin A4 in clear cell renal cell carcinoma: Impact on membrane repair, transcriptional signatures, and composition of the tumor microenvironment. iScience (2025). Walentek P. Mucociliary cell type compositions – bridging the gap between genes and emergent tissue functions. Cells Dev (2025). Tschongov T, Konwar S, Kleindienst J, Dabrowska-Schlepp P, Busch A, Schaaf A, Schell C, Rogg M, Häffner K. Effective long-term treatment with moss-produced factor H by overcoming the antibody response in a mouse model of C3G. Front Immunol (2025). Elcin-Guinot S, Lagies S, Avi-Guy Y, Neugebauer D, Huber TB, Schell C, Kammerer B, Römer W. Lectin-Based Substrate Detection in Fabry Disease Using the Gb3-Binding Lectins StxB and LecA. Int J Mol Sci (2025). Müller M, Zodel K, Abhari BA, Cuomo F, Nizamuddin S, Metzger P, Boerries M, Timmers HTM, Frew IJ. KDM5C and KDM5D mutations have different consequences in clear cell renal cell carcinoma cells. Commun Biol (2025). Pal J, Riester M, Ganner A, …, Frew IJ, Kotsis F, Neumann-Haefelin E, Spang A, Diederichs S. Nonstop mutations cause loss of renal tumor suppressor proteins VHL and BAP1 and affect multiple stages of protein translation. Sci Adv (2025). Felixberger PT, Andrieux G, Maul-Pavicic A, …, Boerries M, Nitschke L, Voll RE, Warnatz K, Keller B. CD21low B cells reveal a unique glycosylation pattern with hypersialylation and hyperfucosylation. Front Immunol (2025). Schumann A, Garbade SF, Beblo S, …, Thimm E, Weinhold N, Williams M, Wortmann S, Grünert SC. Kidney involvement in glycogen storage disease type I: Current knowledge and key challenges. Mol Genet Metab (2025). Braun LM, Giesler S, Andrieux G, …, Boerries M, …, Schell C, …, Becher B, Funke-Lorenz C, Placke JM, Apostolava P, Zeiser R. Adiponectin reduces immune checkpoint inhibitor-induced inflammation without blocking anti-tumor immunity. Cancer Cell (2025).